50% off the $29 audit or $99 Fix-It Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. ブライトパス・バイオ株式会社 just got measured.
4/10 means ブライトパス・バイオ株式会社 is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About ブライトパス・バイオ株式会社
ブライトパス・バイオはがん治療の革新とフロンティア拡大をもたらしつつある「がん免疫療法」の開発を行う創薬ベンチャーです。後期臨床試験段階から創薬探索段階までの様々な医薬品形態のパイプラインを持ち、グローバルで開発を行っています。
Details
Industry: Technology
brightpathbio.comAI Visibility Breakdown
1
Structured Data
8
Content Structure
5
Entity Clarity
2
E-E-A-T Signals
7
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for ブライトパス・バイオ株式会社.
Source & Attribution
Scored by Engagemii on June 18, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/brightpathbio
Cite this score: Engagemii (2026). "AEO Score for ブライトパス・バイオ株式会社." Retrieved from https://engagemii.com/aeo/brands/brightpathbio
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform